Abstract:Objective To assess the association of BDNF gene Val66Met polymorphism with efficacy of antidepressant treatment and plasma BDNF level.Methods Two hundred and forty-nine ethnic Han Chinese patients with depression(study group),who have met the diagnostic criteria of DSM-Ⅳ,were prescribed with venlafaxine or paroxetine.Two hundred and two healthy individuals were recruited as the control group.General demographic information such as gender,age,educational status,occupation,and marriage status were collected.HAMD-17 was adopted as the primary rating tool to evaluate the severity of depression on the baseline and at the end of 1st,2nd,4th,6th week of treatment.PCR-restriction fragment length polymorphism was applied to determine the Val66Met polymorphism of the BDNF gene in the two groups.Plasma BDNF concentration was measured with ELISA before and after 6 weeks of treatment.Results No significant differences have been found in HAMD scores and reduction of HAMD scores on the baseline and at the end of 1 st,2nd,4th,6th weeks of treatment for each genotype.Nor were significant differences found in the Val66Met genotypes and allelic frequency between patients who achieved remission or not after 6 weeks' treatment as well as the healthy volunteers.The plasma BDNF level in depression patients was lower than that in healthy controls.The BDNF level has increased significantly after 6 weeks' treatment with both venlafaxine and paroxetine,but was still lower than the healthy controls.The BDNF level in the patients achieved remission who were treated with venlafaxine was similar to the normal controls,while those treated with paroxetine was still lower than normal controls.The BDNF level in patients who have not achieved remission was lower than normal controls.The BDNF level was not associated with the Val66Met polymorphism on the baseline and the end of 6th week.Conclusion No association has been found between the efficacy of venlafaxine or paroxetine and the BDNF Val66Met polymorphism.The BDNF level of patients with depression is significantly lower than healthy controls on the baseline,and can be enhanced with the treatment.Particularly,the BDNF level in patients who achieved remission after the treatment of venlafaxine can rise to normal.The level of BDNF has certain value in the forecasting of efficacy in the anti-depression therapy.BDNF level is not associated with the Val66Met polymorphism of the BDNF gene.

Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and the BDNF Val66Met Polymorphism in Suicide: a Prospective Study in Patients with Depressive Disorder

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level

Plasma Level of Brain-Derived Neurotrophic Factor and the Related Analysis in Depressive Patients with Suicide Attempt

Effect of brain-derived neurotrophic factor Val66Met polymorphism and environmental factors on antidepressant treatment

Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response.

Association of Brain-Derived Neurotrophic Factor G196A and Attempted Suicide: A Case-Control Study in Rural China.

Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder.

BDNF Val66Met Polymorphism and Anxiety/depression Symptoms in Schizophrenia in a Chinese Han Population.

Correlation Between Sleep Electroencephalogram, Brain-Derived Neurotrophic Factor, AVPR1B Gene Polymorphism, and Suicidal Behavior in Patients with Depression

Brain-derived Neurotrophic Factor’s Val66Met and C270T Polymorphisms Influence Citalopram/Escitalopram Response in Chinese Patients with Major Depressive Disorder

Relationship between the effect of modified electroconvulsive therapy and brain-derived neurotrophic factor(BDNF) gene polymorphism in patients with major depressive disorder

Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects

Effects of Polymorphisms of Serotonin Transporter Promoter (5-HTTLPR) and Brain Derived Neurotrophic Factor Gene (G196A Rs6265) on the Risk of Major Depressive Disorder in the Chinese Han Population.

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

Lack of association between BDNF Val66Met gene polymorphism and late-onset depression in a Chinese Han population.

The Relationship between Level of BDNF in Serum and Depressive Symptoms and Cognitive Dysfunction of Patients with Major Depression

Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD